Tanaka Chemical Corporation carries a market capitalization of 13.27B, placing it among publicly traded companies globally. Its enterprise value stands at 32.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.27B |
| Enterprise Value | 32.72B |
Tanaka Chemical Corporation currently has 32.53M shares outstanding.
| Shares Outstanding | 32.53M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Tanaka Chemical Corporation trades at a trailing price-to-earnings ratio of 24.08. The price-to-sales ratio is 1.16, and the price-to-book ratio stands at 2.36.
| PE Ratio | 24.08 |
| PS Ratio | 1.16 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 1.49 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Tanaka Chemical Corporation trades at an EV/EBITDA multiple of 32.81 and an EV/FCF ratio of 964.16. The EV/Sales ratio of 1.40 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.81 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.40 |
| EV / EBITDA | 32.81 |
| EV / EBIT | 32.81 |
| EV / FCF | 964.16 |
Tanaka Chemical Corporation maintains a current ratio of 1.72, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 55.31, indicating elevated leverage, while an interest coverage ratio of 31.16 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.72 |
| Quick Ratio | 0.44 |
| Debt / Equity | 55.31 |
| Debt / EBITDA | 10.08 |
| Interest Coverage | 31.16 |
| Return on Equity (ROE) | 10.77 |
| Return on Assets (ROA) | 3.20 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 4.12 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.97 |
Over the trailing twelve months, Tanaka Chemical Corporation has paid -64.00M in income taxes, reflecting an effective tax rate of 7.48.
| Income Tax | -64.00M |
| Effective Tax Rate | 7.48 |
Tanaka Chemical Corporation's stock has declined approximately -17.24138% over the past 52 weeks. The 50-day moving average sits at 417.02, while the 200-day moving average is 411.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.24138% |
| 50-Day Moving Average | 417.02 |
| 200-Day Moving Average | 411.96 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Tanaka Chemical Corporation generated 23.37B in revenue and converted that into 1.12B in net income, yielding earnings per share of 34.56. EBITDA reached 997.00M, while operating income came in at 997.00M.
| Revenue | 23.37B |
| Gross Profit | 2.04B |
| Operating Income | 997.00M |
| Pretax Income | 1.06B |
| Net Income | 1.12B |
| EBITDA | 997.00M |
| EBIT | 997.00M |
| Earnings Per Share (EPS) | 34.56 |
Tanaka Chemical Corporation holds 4.40B in cash and equivalents against 10.05B in total debt, resulting in a net debt position of 5.66B. Total book value stands at 11.47B, with working capital of 7.26B providing operational flexibility.
| Cash & Cash Equivalents | 4.40B |
| Total Debt | 10.05B |
| Net Debt | 5.66B |
| Equity (Book Value) | 11.47B |
| Book Value Per Share | 352.59 |
| Working Capital | 7.26B |
Tanaka Chemical Corporation operates with a gross margin of 8.72, reflecting its pricing power and cost economics. The operating margin of 4.27 and net profit margin of 4.81 provide insight into operational efficiency.
| Gross Margin | 8.72 |
| Operating Margin | 4.27 |
| Pretax Margin | 4.54 |
| Profit Margin | 4.81 |
| EBITDA Margin | 4.27 |
Tanaka Chemical Corporation posts an Altman Z-Score of 2.00, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.00 |